Literature DB >> 10738086

Low-dose radiotherapy selectively reduces adhesion of peripheral blood mononuclear cells to endothelium in vitro.

P M Kern1, L Keilholz, C Forster, R Hallmann, M Herrmann, M H Seegenschmiedt.   

Abstract

BACKGROUND AND
PURPOSE: The anti-inflammatory effect of low-dose radiotherapy (LD-RT) still is not understood. The adhesion of leukocytes to endothelial cells (EC) of the vessel wall is the initial event of tissue invasion, and thus, crucially contributes to the regulation of inflammation. We investigated the influence of LD-RT on the adhesion process in vitro.
MATERIALS AND METHODS: Isolated peripheral-blood-mononuclear-cells (PBMC) were incubated with an activated murine endothelioma cell-line under shear conditions at 4 degrees C after irradiation with single doses between 0.1 and 10.0 Gy. Adherent cells were counted microscopically and compared to a non-irradiated control. In parallel, viability and expression of adhesion molecules, especially of L-selectin, and lineage-specific markers on the cell surface were determined by dye exclusion and cytofluorometry, respectively. Modulation of adhesion by soluble L-selectin was tested in the adhesion assay.
RESULTS: Radiation doses of 0.1-0.5 Gy reduced the adhesion of viable PBMC to EC in vitro by 70% of the control level 4 h after irradiation. Leukocytes showed a marked reduction of L-selectin expression after LD-RT. Soluble L-selectin can inhibit the adhesion of PBMC to EC.
CONCLUSION: The anti-inflammatory effect of LD-RT might, in part, be due to the reduction in the adhesion of PBMC to EC. This reduction in adhesion might be a consequence of the reduced expression of L-selectin on the surface of PBMC, and the inhibition of adherence by soluble L-selectin shed by PBMC in vitro.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10738086     DOI: 10.1016/s0167-8140(00)00141-9

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  34 in total

Review 1.  [Radiotherapeutic management of lymphatic fistulas : An effective but disregarded therapy option].

Authors:  D Habermehl; G Habl; H-H Eckstein; F Meisner; S E Combs
Journal:  Chirurg       Date:  2017-04       Impact factor: 0.955

2.  Is anti-inflammatory radiotherapy an effective treatment in trochanteritis?

Authors:  Izaskun Valduvieco; Albert Biete; Luis A Moreno; Xavier Gallart; Angels Rovirosa; Jordi Saez; Carlos Plana; Pilar Peris
Journal:  Br J Radiol       Date:  2016-11-25       Impact factor: 3.039

Review 3.  Anti-inflammatory effects of low-dose radiotherapy. Indications, dose, and radiobiological mechanisms involved.

Authors:  M Arenas; S Sabater; V Hernández; A Rovirosa; P C Lara; A Biete; J Panés
Journal:  Strahlenther Onkol       Date:  2012-08-22       Impact factor: 3.621

4.  Successful treatment of chronic recurrent multifocal osteomyelitis using low-dose radiotherapy : A case report.

Authors:  Christian T Dietzel; Christoph Schäfer; Dirk Vordermark
Journal:  Strahlenther Onkol       Date:  2016-11-07       Impact factor: 3.621

5.  Flying by the seat of our pants: is low dose radiation therapy for COVID-19 an option?

Authors:  Dörthe Schaue; William H McBride
Journal:  Int J Radiat Biol       Date:  2020-05-26       Impact factor: 2.694

6.  DEGRO practical guidelines for radiotherapy of non-malignant disorders: Part I: physical principles, radiobiological mechanisms, and radiogenic risk.

Authors:  Berthold Reichl; Andreas Block; Ulrich Schäfer; Christoph Bert; Reinhold Müller; Horst Jung; Franz Rödel
Journal:  Strahlenther Onkol       Date:  2015-06-28       Impact factor: 3.621

7.  Effect of irradiation on gene expression of rat liver adhesion molecules: in vivo and in vitro studies.

Authors:  Federico Moriconi; Ihtzaz Malik; Ghayyor Ahmad; Joszef Dudas; Margret Rave-Fränk; Hilke Vorwerk; Andrea Hille; Clemens Friedrich Hess; Giuliano Ramadori; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2009-08-28       Impact factor: 3.621

8.  Low and moderate doses of ionizing radiation up to 2 Gy modulate transmigration and chemotaxis of activated macrophages, provoke an anti-inflammatory cytokine milieu, but do not impact upon viability and phagocytic function.

Authors:  R Wunderlich; A Ernst; F Rödel; R Fietkau; O Ott; K Lauber; B Frey; U S Gaipl
Journal:  Clin Exp Immunol       Date:  2015-01       Impact factor: 4.330

Review 9.  Do non-targeted effects increase or decrease low dose risk in relation to the linear-non-threshold (LNT) model?

Authors:  M P Little
Journal:  Mutat Res       Date:  2010-01-25       Impact factor: 2.433

10.  Immunomodulatory properties and molecular effects in inflammatory diseases of low-dose x-irradiation.

Authors:  Franz Rödel; Benjamin Frey; Katrin Manda; Guido Hildebrandt; Stephanie Hehlgans; Ludwig Keilholz; M Heinrich Seegenschmiedt; Udo S Gaipl; Claus Rödel
Journal:  Front Oncol       Date:  2012-09-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.